Secretome as neuropathology-targeted intervention of Parkinson’s disease

Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease, characterized by apoptosis of dopaminergic neurons in substansia nigra pars compacta (SNpc) caused by ⍺-synuclein aggregation. The use of secretomes released by medicinal signaling cells (MSCs) is one the promi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardianto, Christian, Shen, Robert, Barus, Jimmy F.A., Sasmita, Poppy Kristina, Turana, Yuda, Lilis, Lilis, Sidharta, Veronika Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441294/
https://www.ncbi.nlm.nih.gov/pubmed/36092507
http://dx.doi.org/10.1016/j.reth.2022.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441294/
https://www.ncbi.nlm.nih.gov/pubmed/36092507
http://dx.doi.org/10.1016/j.reth.2022.08.003

Ejemplares similares